Quick Info
Status
Currently Recruiting
Estimated Enrollment
160
Phase
-
Treatment Type
Sample Collection (patient registry)
Trial Type
Observational
Sponsor
Primary Investigator
Bjorn Oskarsson, MD
Contact Information
  • 904-953-6523
Locations
Jacksonville, 32224
Trial Goal
Biobanks
PALS tissues help scientists identify potential biomarkers and drugs
Tests to Expect
Blood Draw
Skin Biopsy
Update Notes
No significant updates
6/6/2019
Principal investigator updated
3/23/2018
No significant updates
3/23/2017
No significant updates.
1/5/2016
No significant updates.
4/15/2015
Contact information updated.
9/26/2014
No significant updates.
9/17/2014
No significant updates.
7/16/2013
Protocol information updated
1/29/2013

Other Information

Purpose
This study is intended to obtain clinical information and establish a repository of DNA, RNA, peripheral blood monocyte, lymphocyte and skin tissue samples from people with ALS and related neurodegenerative motor neuron diseases, people with a family history of these conditions, and healthy people with no family history of these disorders. The samples will be used in future research to learn about how these disorders affect people, what causes these conditions, and how the investigators can tell when someone has this kind of disease. Future research may also include the generation of stem cells from stored blood cell and skin cell samples. Participants will not be paid for taking part in this study.
Eligibility
18 years and older. All genders. Accepting healthy volunteers.
Details
Enrolling by invitation. This study will establish a repository of stored DNA, RNA, monocyte, lymphocyte, and skin fibroblast samples from people with ALS and ALS-FTD, subjects with a family history of ALS who do not have ALS or ALS-FTD, and subjects with no personal history of ALS or dementia, to support future translational and basic research studies on ALS and related neurodegenerative disorders.
Collaborator(s)
    -
News Articles and Summaries
    -
ALS Forum
-
Trial Protocol as Published on Clinicaltrials.gov
NCT01699451 (First Published: 9/30/2012)